Susan M. Dallabrida, PhD
Vice President of Clinical Science and Consulting
Dr. Susan Dallabrida is the eCOA Vice President of Clinical Science and Consulting at ERT. She has over 22 years of experience leading clinical research, trial design and strategy, and product development. She is expert in instrument development and psychometric validation and conceptual equivalence/ content validity studies for eCOA/COA. She interacts with regulatory agencies such as the FDA to support development and use of PRO’s for labeling claims. She is expert in eCOA/COA design for clinical trials and optimizing data quality via incorporation of outcomes reliability training for site raters, subjects and caregivers, clinical data surveillance and clinical data validation. She conducts research to determine how to optimize eCOA/COA data quality and capture. Dr. Dallabrida presents educational webinars and lectures on effective eCOA design and use in clinical trials and is frequently asked to speak on why rater training matters in clinical trials. She has led cross-functional drug discovery and product development teams and collaborations in diverse areas including: oncology, cardiovascular disease, hemophilia, dermatology, obesity, and vascular disorders. She earned a B.A. in Chemistry and a B.S. in Biology, both cum laude, from Bloomsburg University; and a Ph.D. in Biochemistry and Molecular Biology from Pennsylvania State University. Dr. Dallabrida has significant regulatory experience in the US and internationally for biologics and small molecules. She has a broad background in scientific presentations and writing with 21 publications, 14 grants, 3 patents, 20 awards, 45 conference presentations, and 37 abstracts. In 2014, PharmaVOICE named Dr. Dallabrida as one of the 100 most inspiring professionals in the life sciences industry.